FTC Requests Additional Info On $16.5B Novo-Catalent Deal
By Tom Zanki · May 3, 2024, 4:46 PM EDT
The Federal Trade Commission is seeking additional information on Novo Holdings' planned $16.5 billion acquisition of pharmaceutical services company Catalent in order to examine whether the blockbuster deal passes antitrust muster,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login